US4242354A
Expired / Lapsed
US
⏱️ 0.0 years remaining
2-(2-Thenolythio)-propionylglycine: method for its preparation and pharmaceutical formulations containing said compound
Assignee: Mediolanum Farmaceutici SpA
•
Filing: 1979-04-04
•
Granted: 1980-12-30
•
Expires: 1999-04-04
Abstract
Abstract The invention provides 2-(2-thenoylthio)-propionylglycine, a novel compound having liver-protective, mucolytic and bronchial-spasm relieving activity.
Inventors
- 👤 Franco Bolasco
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 17:06
CPC Classifications
C; C07; C07D; C07D333/00; C07D333/02; C07D333/04; C07D333/26; C07D333/38; A; A61; A61P; A61P1/00; A61P1/16; A61P11/00; A61P11/08; A61P11/10
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
19 words
2-(2-thenoylthio)-propionylglycine as a new compound, characterized by the structural formula (I) ##STR3## as well as its pharmacologically acceptable salts.
Claim 2
Dependent Claim
19 words
2-(2-thenoylthio)-propionylglycine as a new compound, characterized by the structural formula (I) ##STR3## as well as its pharmacologically acceptable salts.
Claim 3
Dependent Claim
40 words
Pharmaceutical composition for the treatment of acute and chronic liver diseases as well as poisoning consequences, characterized by the fact that 2-(2-thenoylthio)-propionylglycine, with the structural formula (I), and/or one of its pharmacologically acceptable salt, is contained as the active ingredient.
Claim 4
Dependent Claim
40 words
Pharmaceutical composition for the treatment of acute and chronic liver diseases as well as poisoning consequences, characterized by the fact that 2-(2-thenoylthio)-propionylglycine, with the structural formula (I), and/or one of its pharmacologically acceptable salt, is contained as the active ingredient.
Claim 5
Dependent Claim
34 words
Pharmaceutical composition, endowed with a mucolytic and bronchial-spasm relieving activity, characterized by the fact that 2-(2-thenoylthio)-propionylglycine, with the structural formula (I), and/or one of its pharmacologically acceptable salts, is contained as the active ingredient.
Claim 6
Dependent Claim
34 words
Pharmaceutical composition, endowed with a mucolytic and bronchial-spasm relieving activity, characterized by the fact that 2-(2-thenoylthio)-propionylglycine, with the structural formula (I), and/or one of its pharmacologically acceptable salts, is contained as the active ingredient.
Claim 7
Dependent Claim
23 words
Pharmaceutical composition, according to claim 2, characterized by the fact that the sodium salt of 2-(2-thenoylthio)-propionylglycine (I) is contained as the active ingredient.
Claim 8
Dependent Claim
20 words
Pharmaceutical composition, according to claim 2, available in the pharmaceutical dosage form of tablets, suppositories, injectable ampuls, syrup or aerosol.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-12-30 | 1984-06-30 | 1984-12-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-12-30 | 1988-06-30 | 1988-12-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-12-30 | 1992-06-30 | 1992-12-30 | $7700.00 | Window Closed / Lapsed |